Variable | Ntotal | Statistic* |
---|---|---|
Age (years) | 997 | 65 (12–94) |
Gender | ||
Female | 446 | 45% |
Male | 553 | 55% |
Race | ||
Caucasian | 803 | 82.4 |
African-American | 167 | 17.1 |
Other | 4 | 0.5 |
ECOG PS | ||
0 | 34 | 3% |
1 | 150 | 16% |
2 | 252 | 26% |
3 | 403 | 42% |
4 | 120 | 12% |
Primary cancer site | ||
Lung | 239 | 24% |
Breast | 87 | 9% |
Colorectal | 79 | 8% |
Prostate | 70 | 7% |
Unknown primary | 62 | 6% |
Pancreas | 57 | 6% |
Head and neck | 46 | 5% |
Kidney | 44 | 4% |
Lymphoma | 32 | 3% |
Oesophagus | 31 | 3% |
Bladder | 26 | 3% |
Myeloma | 19 | 2% |
Melanoma | 17 | 2% |
Cervix | 16 | 2% |
Ovary | 14 | 1% |
Uterus | 10 | 1% |
Leukaemia | 9 | 1% |
Other | 142 | 14% |
Survival from diagnosis (months) | 838 | 14 (0–547) |
Survival after referral (months) | 598 | 2 (0.5–33) |
*N (%) for categorical variables; median (range) for continuous variables.
ECOG, Eastern Cooperative Oncology Group; PS, performance score.